Abstract
A study of a well-designed androgen-mustard conjugate provides evidence supporting a novel mechanism for its selective toxicity in androgen-receptor- positive cancer cells [1]. This represents a solid step forward on the path toward effective hybrid toxins for targeted cancer therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 719-721 |
| Number of pages | 3 |
| Journal | Chemistry and Biology |
| Volume | 12 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2005 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmacology
- Drug Discovery
- Clinical Biochemistry
Fingerprint
Dive into the research topics of 'Designing effective hybrid toxins'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS